Arch Therapeutics Inc (ARTH)

[bryan2464]

Avtar Dhillon, the Vancouver man facing charges from the U.S. Securities and Exchange Commission for a scheme in which he and others improperly sold millions of dollars worth of stock on the U.S. markets, has refused to answer the allegations against him. The SEC claims that Mr. Dhillon concealed sales of large blocks of shares that he held in two companies. The overall scheme involved the sale of $45.6-million worth of shares, with Mr. Dhillon receiving at least $2.6-million, the SEC says. (All figures are in U.S. dollars.)

https://www.stockwatch.com/News/Item?bid=Z-U:*SEC-3188331&symbol=*SEC®ion=U